These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 7621253)

  • 1. A carcinoembryonic antigen polynucleotide vaccine for human clinical use.
    Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Pike J; Curiel DT
    Cancer Gene Ther; 1995 Mar; 2(1):33-8. PubMed ID: 7621253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine.
    White SA; LoBuglio AF; Arani RB; Pike MJ; Moore SE; Barlow DL; Conry RM
    J Gene Med; 2000; 2(2):135-40. PubMed ID: 10809147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.
    Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Curiel DT
    Gene Ther; 1995 Jan; 2(1):59-65. PubMed ID: 7712333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to a carcinoembryonic antigen polynucleotide vaccine.
    Conry RM; LoBuglio AF; Kantor J; Schlom J; Loechel F; Moore SE; Sumerel LA; Barlow DL; Abrams S; Curiel DT
    Cancer Res; 1994 Mar; 54(5):1164-8. PubMed ID: 8118800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
    McLaughlin JP; Schlom J; Kantor JA; Greiner JW
    Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system.
    Lund LH; Andersson K; Zuber B; Karlsson A; Engström G; Hinkula J; Wahren B; Winberg G
    Cancer Gene Ther; 2003 May; 10(5):365-76. PubMed ID: 12719706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.
    Conry RM; Curiel DT; Strong TV; Moore SE; Allen KO; Barlow DL; Shaw DR; LoBuglio AF
    Clin Cancer Res; 2002 Sep; 8(9):2782-7. PubMed ID: 12231517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF).
    Lima J; Jenkins C; Guerrero A; Triozzi PL; Shaw DR; Strong TV
    Vaccine; 2005 Jan; 23(10):1273-83. PubMed ID: 15652670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
    Aarts WM; Schlom J; Hodge JW
    Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
    Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
    Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R
    Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
    Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
    J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line.
    Robbins PF; Kantor JA; Salgaller M; Hand PH; Fernsten PD; Schlom J
    Cancer Res; 1991 Jul; 51(14):3657-62. PubMed ID: 1712245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a messenger RNA polynucleotide vaccine vector.
    Conry RM; LoBuglio AF; Wright M; Sumerel L; Pike MJ; Johanning F; Benjamin R; Lu D; Curiel DT
    Cancer Res; 1995 Apr; 55(7):1397-400. PubMed ID: 7882341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.
    Kantor J; Irvine K; Abrams S; Snoy P; Olsen R; Greiner J; Kaufman H; Eggensperger D; Schlom J
    Cancer Res; 1992 Dec; 52(24):6917-25. PubMed ID: 1458480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant.
    Ponnazhagan S; Mahendra G; Lima J; Aldrich WA; Jenkins CB; Ren C; Kumar S; Kallman L; Strong TV; Shaw DR; Triozzi PL
    Hum Gene Ther; 2004 Sep; 15(9):856-64. PubMed ID: 15353040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.